Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Biometry Research Group

Publications

View All  |  2014-2010  |  2009-2000  |  1999-1990  |  1989-1980  |  1979-1970

  • Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J for the National Lung Screening Trial Research Team. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013 Sep 5;369(10):920-31.
    [ PubMed Abstract ]
  • Baker SG. Additional thoughts on causal inference, probability theory, and graphical insights. Exit Disclaimer Stat Med. 2013 (32) 4334-37.
  • Baker SG. Causal inference, probability theory, and graphical insights. Stat Med. 2013 May 10.
    [ PubMed Abstract ]
  • Baker SG. Letter to the editor: Comment on Hubbard and Miglioretti (2013). Consider also a selection model for the cumulative risk of false positive screening tests. Biometrics. 2013 Dec;69(4):1084.
    [ PubMed Abstract ]
  • Baker SG. Letter to the editor: The tangent classifier. The American Statistician 2013;67:64-65.
  • Baker SG. Paradox-driven cancer research. Exit Disclaimer Disruptive Science and Technology. 2013 1(3): 143-48.
  • Baker SG. Recognizing paradigm instability in theories of carcinogenesis. Exit Disclaimer British Journal of Medicine and Medical Research. Nov 8, 2013.
  • Baker SG. Remarks on "A simple decision analytic solution to the comparison of two binary diagnostic tests" by Vickers et al." Stat Med 2013;32(4):718.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Surrogate endpoint analysis: an exercise in extrapolation. J Natl Cancer Inst 2013;105(5):316-320.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. The risky reliance on small surrogate endpoint studies when planning a large prevention trial. Journal of the Royal Statistical Society, Series A 2013;176(2):603-608.
    [ PubMed Abstract ]
  • Baker SG, Lindeman K. L Revisiting a discrepant result: a propensity score analysis, the paired availability design for historical controls, and a meta-analysis of randomized trials. Exit Disclaimer British Journal of Causal Inference. 2013 1(1):51-82.
  • Berger VW. On the insufficiency of reporting masking. J Rehabil Med 20 13;45(2):221-222.
    [ PubMed Abstract ]
  • Berger VW. Reply to Letter-to-the-Editor: Efficacy and degree of bias in knee injury prevention studies: a systematic review of RCTs. Clin Orthop Relat Res 2013;471(1):341-342.
    [ PubMed Abstract ]
  • Major JM, Graubard BI, Dodd KW, Iwan A, Alexander BH, Linet MS, Freedman DM. Variability and reproducibility of circulating vitamin D in a nationwide U.S. population. J Clin Endocrinol Metab 2013;98(1):97-104.
    [ PubMed Abstract ]
  • Mir MC, Stephenson AJ, Grubb RL 3rd, Black A, Kibel AS, Izmirlian G. Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2241-9.
    [ PubMed Abstract ]
  • Murad H, Kipnis V, Freedman LS. Estimating and testing interactions when explanatory variables are subject to non-classical measurement error. Stat Meth Med Res. 2013 Dec 11 [epub ahead of print].
    [ PubMed Abstract ]
  • Palys KE, Berger VW. Re: Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review. J Natl Cancer Inst 2013;105(3):244-245.
    [ PubMed Abstract ]
  • Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN. Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the Prostate, Lung, Colorectal, and Ovarian Screening Trial. Obstet Gynecol 2013;121(1):25-31.
    [ PubMed Abstract ]
  • Pepper JA, Vydelingum NA, Dunn BK, Fagerstrom RM: Agent-Based Models in Cancer Prevention Research; in Agent-Based Models: Theory, Developments & Applications Exit Disclaimer, (pp 105-116) . Nova Science Publishers, Hauppauge, New York.
  • Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013 Aug 26.
    [ PubMed Abstract ]
  • Rosenfeld S. Are the somatic mutation and tissue organization field theories of carcinogenesis incompatible? Cancer Inform. 2013 Dec 1;12:221-9.
    [ PubMed Abstract ]
  • Rosenfeld S. Global consensus theorem and self-organized criticality: unifying principles for understanding self-organization, swarm intelligence and mechanisms of carcinogenesis. Gene Regul Syst Bio. 2013;7:23-39.
    [ PubMed Abstract ]
  • Subar AF, Midthune D, Tasevska N, Kipnis V, Freedman LS. Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study. Eur J Clin Nutr. 2013 Aug;67(8):863-7.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team. Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S.Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013 May 23;368(21):1980-91.
    [ PubMed Abstract ]
  • Van Calster B, Vickers AJ, Pencina MJ, Baker SG, Timmerman D, Steyerberg EW. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures. Med Decis Making. 2013 May;33(4):490-501.
    [ PubMed Abstract ]
  • Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B. Who should be included in a clinical trial of screening for bladder cancer?: A decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer 2013;119(1):143-149.
    [ PubMed Abstract ]
  • Aktipis CA, Maley CC, Pepper JW. Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prev Res (Phila) 2012;5(2):266-275.
    [ PubMed Abstract ]
  • Anderson CM, Burns DM, Dodd KW, Feuer EJ. Chapter 2: Birth-cohort-specific estimates of smoking behaviors for the U.S. population. Risk Anal 2012;32 Suppl 1:S14-24.
    [ PubMed Abstract ]
  • Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia C, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC, and for the PLCO Project Team. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104(2):125-132.
    [ PubMed Abstract ]
  • Badurdeen DS, Umar NA, Begum R, Sanderson AK 2nd, Jack M, Mekasha G, Kwagyan J, Smoot DT, Laiyemo AO. Timing of procedure and compliance with outpatient endoscopy among an underserved population in an inner-city tertiary institution. Ann Epidemiol 2012;22(7):531-535.
    [ PubMed Abstract ]
  • Bailey RL, Mills JL, Yetley EA, Gahche JJ, Pfeiffer CM, Dwyer JT, Dodd KW, Sempos CT, Betz JM, Picciano MF. Serum unmetabolized folic acid in a nationally representative sample of adults =60 years in the United States, 2001-2002. Food Nutr Res 2012;56.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Evaluating a new marker for risk prediction: decision analysis to the rescue. Discov Med 2012;14(76):181-188.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS, Sargent DJ, Bonetti M. Biomarkers, subgroup evaluation, and clinical trial design. Discov Med 2012;13(70):187-192.
    [ PubMed Abstract ]
  • Baker SG, Sargent DJ, Buyse M, Burzykowski T. Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time. Biometrics 2012;68(1):248-257.
    [ PubMed Abstract ]
  • Baker SG, Van Calster B, Steyerberg EW. Evaluating a new marker for risk prediction using the test tradeoff: an update. Int J Biostat 2012;8(1):article 5.
    [ PubMed Abstract ]
  • Baker SG. Comment on Nie et al. (2011), biometrics, early view. Biometrics 2012;68(3):992.
    [ PubMed Abstract ]
  • Baker SG. Gene signatures revisted. J Natl Cancer Inst 2012;104(4):262-263.
    [ PubMed Abstract ]
  • Baker SG. Paradoxes in carcinogenesis should spur new avenues of research: an historical perspective. Journal of Disruptive Science and Technology 2012;1(2):100-107.
  • Berger VW, Izmirlian G, Knoll D. Discussion of the paper of Ghosh, Taylor, and Sargent. Biometrics 2012;68(1):239-241.
    [ PubMed Abstract ]
  • Berger VW, Palys K. Medical research: what is wrong with this picture? The International Journal of Person Centered Medicine 2012;2(4):707-715.
  • Berger VW. Conservative handling of cluster randomized trials. Clin Trials 2012;9(3):371.
    [ PubMed Abstract ]
  • Berger VW. Conservative handling of missing data. Contemp Clin Trials 2012;33(3):460.
    [ PubMed Abstract ]
  • Berger VW. Conservative handling of missing information. J Clin Epidemiol 2012;65(11):1237-1238.
    [ PubMed Abstract ]
  • Berger VW. De facto masking and other measures to prevent contamination. J Clin Epidemiol 2012;65(11):1236.
    [ PubMed Abstract ]
  • Berger VW. Internal validity and the risk of bias: a case for a comprehensive review. J Anesth 2012;26(5):802-803.
    [ PubMed Abstract ]
  • Berger VW. Keep digging until we get the result we want? Contemp Clin Trials 2012;33(1):12.
    [ PubMed Abstract ]
  • Berger VW. Out of the frying pan and into the fire? Biometrics 2012;68(3):990.
    [ PubMed Abstract ]
  • Berger VW. Two-stage randomized trials: outstanding issues. Stat Med 2012;31(29):4142; author reply 4143-4144.
    [ PubMed Abstract ]
  • Brown DA, Hance KW, Rogers CJ, Sansbury LB, Albert PS, Murphy G, Laiyemo AO, Wang Z, Cross AJ, Schatzkin A, Danta M, Srasuebkul P, Amin J, Law M, Breit SN, Lanza E. Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? Cancer Epidemiol Biomarkers Prev 2012;21(2):337-346.
    [ PubMed Abstract ]
  • Carroll RJ, Midthune D, Subar AF, Shumakovich M, Freedman LS, Thompson FE, Kipnis V. Taking advantage of the strengths of 2 different dietary assessment instruments to improve intake estimates for nutritional epidemiology. Am J Epidemiol 2012;175;(4):340-347.
    [ PubMed Abstract ]
  • Dodd KW, Midthune D, Kipnis V. Re: "Application of a repeat-measure biomarker measurement error model to 2 validation studies: examination of the effect of within-person variation in biomarker measurements". Am J Epidemiol 2012;175(1):84-85.
    [ PubMed Abstract ]
  • Doubeni CA, Laiyemo AO, Major JM, Schootman M, Lian M, Park Y, Graubard BI, Hollenbeck AR, Sinha R. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer 2012;118(14):3636-3644.
    [ PubMed Abstract ]
  • Doubeni CA, Major JM, Laiyemo AO, Schootman M, Zauber AG, Hollenbeck AR, Sinha R, Allison J. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst 2012;104(18):1353-1362.
    [ PubMed Abstract ]
  • Doubeni CA, Schootman M, Major JM, Stone RA, Laiyemo AO, Park Y, Lian M, Messer L, Graubard BI, Sinha R, Hollenbeck AR, Schatzkin A. Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health 2012;102(4):680-688.
    [ PubMed Abstract ]
  • George SM, Thompson FE, Midthune D, Subar AF, Berrigan D, Schatzkin A, Potischman N. Strength of the relationships between three self-reported dietary intake instruments and serum carotenoids: the Observing Protein and Energy Nutrition (OPEN) Study. Public Health Nutr 2012;15(6):1000-1007.
    [ PubMed Abstract ]
  • Higgins AY, Doubeni AR, Phillips KL, Laiyemo AO, Briesacher B, Tjia J, Doubeni CA. Self-reported colorectal cancer screening of Medicare beneficiaries in family medicine vs. internal medicine practices in the United States: a cross-sectional study. BMC Gastroenterol 2012;12(1):23.
    [ PubMed Abstract ]
  • Jackson DS, Egbuonnu N, Umunakwe C, Fullum TM, Ford DH, Anders KB, McDonald-Pinkett S, Smoot DT, Laiyemo AO. Scheduled out-patient endoscopy and lack of compliance in a minority serving tertiary institution. Am J Med Sci 2012;344(3):194-198.
    [ PubMed Abstract ]
  • Kipnis V, Midthune D, Freedman LS, Carroll RJ. Regression calibration with more surrogates than mismeasured variables. Stat Med 2012;31(23):2713-2732.
    [ PubMed Abstract ]
  • Kirkpatrick SI, Dodd KW, Reedy J, Krebs-Smith SM. Income and race/ethnicity are associated with adherence to food-based dietary guidance among US adults and children. J Acad Nutr Diet 2012;112(5):624-635.
    [ PubMed Abstract ]
  • Kirkpatrick SI, Midthune D, Dodd KW, Potischman N, Subar AF, Thompson FE. Reactivity and its association with body mass index across days on food checklists. J Acad Nutr Diet 2012;112(1):110-118.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Badurdeen DS, Murphy G, Marcus PM, Schoen RE, Lanza E, Smoot DT, Cross AJ. Obesity, weight change, and risk of adenoma recurrence: a prospective trial. Endoscopy 2012;44(9):813-818.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiol 2012;36(4):395-399.
    [ PubMed Abstract ]
  • Laiyemo AO. In search of a perfect solution to ensure that "no colon is left behind". Dig Dis Sci 2012;57(2):263-265.
    [ PubMed Abstract ]
  • Liu T, Hossain M, Schepmoes AA, Fillmore TL, Sokoll LJ, Kronewitter SR, Izmirlian G, Shi T, Qian WJ, Leach RJ, Thompson IM, Chan DW, Smith RD, Kagan J, Srivastava S, Rodland KD, Camp DG 2nd. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. J Proteomics 2012;75(15):4747-4757.
    [ PubMed Abstract ]
  • Palys K, Berger VW. On the need for competent evaluation of trial quality. Respir Med 2012;106(12):1804-1805.
    [ PubMed Abstract ]
  • Palys K, Berger VW, Grant W. Unequal allocation and allocation concealment. Stat Med 2012;31(29):4135-4136.
    [ PubMed Abstract ]
  • Pepper JW, Rosenfeld S. The emerging medical ecology of the human gut microbiome. Trends Ecol Evol 2012;27(7):381-384.
    [ PubMed Abstract ]
  • Pepper JW. Drugs that target pathogen public goods are robust against evolved drug resistance. Evol Appl 2012;5(7):757-761.
    [ PubMed Abstract ]
  • Pérez A, Zhang S, Kipnis V, Midthune D, Freedman LS, Carroll RJ. Intake_epis_food(): An R function for fitting a bivariate nonlinear measurement error model to estimate usual and energy intake for episodically consumed foods. J Stat Softw 2012;46(c03):1-17.
    [ PubMed Abstract ]
  • Perna FM, Oh A, Chriqui JF, M√Ęsse LC, Atienza AA, Nebeling L, Agurs-Collins T, Moser RP, Dodd KW. The association of state law to physical education time allocation in US public schools. Am J Public Health 2012;102(8):1594-1599.
    [ PubMed Abstract ]
  • Prorok PC, Miller AB, Kramer BS. Response: Re: Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104(10):793-794.
  • Raji OY, Duffy SW, Agbaje OF, Baker SG, David C. Christiani DC, Cassidy A, Field JK. Predictive accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer: a case-control and cohort validation study. Ann Intern Med 2012;157(4):242-250.
    [ PubMed Abstract ]
  • Roetzheim RG, Freund KM, Corle DK, Murray DM, Snyder FR, Kronman AC, Jean-Pierre P, Raich PC, Holden AE, Darnell JS, Warren-Mears V, Patierno S. Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program. Clin Trials 2012;9(2):176-187.
    [ PubMed Abstract ]
  • Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC. Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Gastrointest Endosc 2012;75(3):612-620.
    [ PubMed Abstract ]
  • Schoen RE, Pinsky PF, Weissfeld L, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD, the PLCO Project Team. Colorectal cancer incidence and mortality in the PLCO Screening Trial. N Engl J Med 2012;366(25):2345-2357.
    [ PubMed Abstract ]
  • Tasevska N, Jiao L, Cross AJ, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A, Potischman N. Sugars in diet and risk of cancer in the NIH-AARP Diet and Health Study. Int J Cancer 2012;130(1):159-169.
    [ PubMed Abstract ]
  • Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; for the PLCO Project Team. Flexible sigmoidoscopy in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: added yield from a second screening examination. J Natl Cancer Inst 2012;104(4):280-289.
    [ PubMed Abstract ]
  • Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, Buys SS. Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer. Gynecol Oncol 2012;2012;125(1):70-74.
    [ PubMed Abstract ]
  • Xu J-L. A property of the generalized proportional hazards model. Far East Journal of Theoretical Statistics 2012;41(2):149-162.
  • Alperson SY, Berger VW. Opposing systematic reviews: the effects of two quality rating instruments on evidence regarding T'ai Chi and bone mineral density in post-menopausal women. J Altern Complement Med 2011;17(5):389-395.
    [ PubMed Abstract ]
  • Andre F, McShane LM, Michiels S, Ransohoff DF, Altman DG, Reis-Filho JS, Hayes DF, Pusztai L. Biomarker studies: a call for a comprehensive biomarker study registry. Nat Rev Clin Oncol 2011;8(3):171-176.
    [ PubMed Abstract ]
  • Baker SG. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome: an alternative approach. Biometrics 2011;67(1):319-323; discussion 323-325.
    [ PubMed Abstract ]
  • Baker SG. Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res 2011;20(3):291-293.
    [ PubMed Abstract ]
  • Baker SG. TOFT better explains experimental results in cancer research than SMT. Bioessays 2011;33(12):919-921.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Systems biology and cancer: promises and perils. Prog Biophys Mol Biol 2011;106(2):410-413.
    [ PubMed Abstract ]
  • Baker SG, Lindeman KS, Kramer BS. Clarifying the role of principal stratification in the paired availability design. Int J Biostat 2011;7(1):Article 25.
    [ PubMed Abstract ]
  • Berger VW. Assessing the quality of surgical trials: further insight. Annals of Surgery 2011;253(2):420-421.
    [ PubMed Abstract ]
  • Berger VW. Assessing the success of masking in acupuncture trials: further insight. Chin J Integr Med 2011;17(7):546.
    [ PubMed Abstract ]
  • Berger VW. Different name, same problems. Contemp Clin Trials 2011;32(8)785.
    [ PubMed Abstract ]
  • Berger VW. Can objective endpoints be manipulated in unmasked trials? Stat Med 2011;30(30):3573-3574.
    [ PubMed Abstract ]
  • Berger VW. Commentary on Lin MF, Hsieh YJ, Fetzer S & Hsu MC (2011) A randomised controlled trial of the effect of music therapy and verbal relaxation on chemotherapy-induced anxiety. Journal of Clinical Nursing 20, 988-999. J Clin Nurs 2011;20(19-20):2980.
    [ PubMed Abstract ]
  • Berger VW. Intent-to-treat: further insight. Res Nurs Health 2011;34(1):4.
    [ PubMed Abstract ]
  • Berger VW. Minimization: not all it's cracked up to be. Clin Trials 2011;8:443, author reply 444.
    [ PubMed Abstract ]
  • Berger VW. Recognizing chronological bias for what it is. Clin Trials 2011;8(6):768; author reply 769.
    [ PubMed Abstract ]
  • Berger VW. Trials: the worst possible design (except for all the rest). The International Journal of Person Centered Medicine 2011;1(3):630-631.
  • Berger VW, Izmirlian G, Knoll D. Discussion of the paper of Ghosh, Taylor, and Sargent. Biometrics 2011 June 22.
    [ PubMed Abstract ]
  • Berger VW, Knoll D. A note on the evaluation of BoNTA trial quality. Inflammopharmacology 2011;19(5):243-244.
    [ PubMed Abstract ]
  • Berger VW, Knoll D. Levels of evidence: further insight on Gugiu and Gugiu. Eval Health Prof 2011;34(1):124-126; discussion 127-130.
    [ PubMed Abstract ]
  • Berger VW, Vali B. Intent-to-randomize corrections for missing data resulting from run-in selection bias in clinical trials for chronic conditions. J Biopharm Stat 2011;21(2):263-270.
    [ PubMed Abstract ]
  • Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu J-L, Prorok PC, Gohagan JK, Berg CD for the PLCO Project Team. Effect of screening on ovarian cancer mortality. the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. JAMA 2011;305(22):2295-2303.
    [ PubMed Abstract ]
  • Crawford ED, Grubb RL, Black A, Andriole GL, Chen MH, Izmirlian G, Berg CD, D'Amico AV. Comorbidity and mortality results from a randomized prostate cancer screening trial J Clin Oncol 2011;29(4):355-361.
    [ PubMed Abstract ]
  • Doubeni CA, Schootman M, Major JM, Torres Stone RA, Laiyemo AO, Park Y, Lian M, Messer L, Graubard BI, Sinha R, Hollenbeck AR, Schatzkin A. Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health 2011 Aug 18.
    [ PubMed Abstract ]
  • Driscoll WW, Pepper JW, Pierson LS, Pierson EA. Spontaneous gac mutants of Pseudomonas biological control strains: cheaters or mutualists? Applied and Environmental Microbiology 2011;77(20):7227-7235.
    [ PubMed Abstract ]
  • Fan YG, Jiang Y, Chang RS, Yao SX, Jin P, Wang W, He J, Zhou QH, Prorok P, Qiao YL, Hu P.Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China. Lung Cancer 2011;72(2):258-263.
    [ PubMed Abstract ]
  • Freedman LS, Midthune D, Carroll RJ, Tasevska N, Schatzkin A, Mares J, Tinker L, Potischman N, Kipnis V. Using regression calibration equations that combine self-reported intake and biomarker measures to obtain unbiased estimates and more powerful tests of dietary associations. Am J Epidemiol 2011;174(11):1238-1245.
    [ PubMed Abstract ]
  • Freedman LS, Schatzkin A, Midthune D, Kipnis V. Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst 2011;103(14):1086-1092.
    [ PubMed Abstract ]
  • Kramer BS, Berg CD, Aberle DR, Prorok PC. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen 2011;18(3):109-111.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiology 2011 Nov 21;Epub ahead of print.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Sanderson AK, Pinsky PF, Badurdeen DS, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Schatzkin A, Cross AJ. Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc 2011;74(2):253-261.
    [ PubMed Abstract ]
  • Lian M, Schootman M, Doubeni CA, Park Y, Major JM, Torres Stone RA, Laiyemo AO, Hollenbeck AR, Graubard BI, Schatzkin A. Geographic variation in colorectal cancer survival and the role of small-area socioeconomic deprivation: a multilevel survival analysis of the NIH-AARP Diet and Health Study cohort. Am J Epidemiol 2011;174(7):828-838.
    [ PubMed Abstract ]
  • Marcus PM, Bergstralh EJ, Kramer BS, Fontana R. The Mayo Lung Project lung cancer mortality findings are unlikely to be biased by a volunteer effect. Eur J Epidemiol 2011;26(6):503-504.
    [ PubMed Abstract ]
  • Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD. The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death. Contemp Clin Trials 2011;32(6):834-840.
    [ PubMed Abstract ]
  • Midthune D, Schatzkin A, Subar AF, Thompson FE, Freedman LS, Carroll RJ, Shumakovich MA, Kipnis V. Validating an FFQ for intake of episodically consumed foods: application to the National Institutes of Health-AARP Diet and Health Study. Public Health Nutr 2011;14(7):1212-1221.
    [ PubMed Abstract ]
  • Oh A, Dodd K, Ballard-Barbash R, Perna FM, Berrigan D. Language use and adherence to multiple cancer preventive health behaviors among Hispanics. J Immigr Minor Health 2011;13(5):849-859.
    [ PubMed Abstract ]
  • Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Rathmell JM, Riley TL, Wright P, Caparaso N, Hu P, Izmirlian G, Pinsky PF, Prorok PC, Kramer BS, Miller AB, Gohagan JK, Berg CD, for the PLCO Project Team. Screening by chest radiograph and lung cancer mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial. JAMA 2011;306(17):1865-1873.
    [ PubMed Abstract ]
  • Pepper JW. Chapter 7: Somatic evolution of acquired drug resistance in cancer. Exit Disclaimer In Gioeli (ed). Targeted Therapies: Mechanisms of Resistance, Springer 2011;127-134.
  • Pignone M, Ransohoff DF. Cross-model comparisons to improve the value of modeling: the case of colorectal cancer screening. Med Decis Making 2011;31(4):524-526.
    [ PubMed Abstract ]
  • Ransohoff DF, Yankaskas B, Gizlice Z, Gangarosa L. Recommendations for post-polypectomy surveillance in community practice. Dig Dis Sci 2011 Jun 23.
    [ PubMed Abstract ]
  • Rosenfeld S. Biomolecular self-defense and futility of high-specificity therapeutic targeting. Gene Regulation and Systems Biology 20115;89-104.
    [ PubMed Abstract ]
  • Rosenfeld S. Critical self-organized self-sustained oscillations in large regulatory networks: towards understanding the gene expression initiation. Gene Regulation and Systems Biology 2011;5:27-40.
    [ PubMed Abstract ]
  • Rosenfeld S. Mathematical descriptions of biochemical networks: stability, stochasticity, evolution. Prog Biophys Mol Biol 2011;106(2):400-409.
    [ PubMed Abstract ]
  • Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011 Jul;106(7):1340-1350.
    [ PubMed Abstract ]
  • Sprouffske K, Pepper JW, Maley CC. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res 2011;4(7):1135-1144.
    [ PubMed Abstract ]
  • Stovsky M, Ponsky L, Vourganti S, Stuhldreher P, Siroky MB, Kipnis V, Fedotoff O, Mikheeva L, Zaslavsky B, Chait A, Jones JS. Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples. Urology 2011;78(3):601-605.
    [ PubMed Abstract ]
  • Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg CD, Prorok PC. Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011;103(13):1058-1068.
    [ PubMed Abstract ]
  • Tasevska N, Cross AJ, Dodd KW, Ziegler RG, Caporaso NE, Sinha R. No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the Prostate, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2011;128(2):402-411.
    [ PubMed Abstract ]
  • Tasevska NA, Midthune D, Potischman N, Subar AF, Cross AJ, Bingham SA, Schatzkin A, Kipnis V. Use of the predictive sugars biomarker to evaluate self-reported total sugars intake in the Observing Protein and Energy Nutrition (OPEN) study. Cancer Epidemiol Biomarkers Prev 2011;20(3):490-500.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team (Fagerstrom RM, Izmirlian G, Marcus PM, Prorok PC). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395-409.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team (Fagersrom RM, Izmirlian G, Marcus PM, Prorok P). The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-253.
    [ PubMed Abstract ]
  • Verkaik-Kloosterman J, Dodd KW, Dekkers AL, van 't Veer P, Ocké MC. A three-part, mixed-effects model to estimate the habitual total vitamin D intake distribution from food and dietary supplements in Dutch young children. J Nutr 2011;141(11):2055-2063.
    [ PubMed Abstract ]
  • Wastney ME, Combs GF, Canfield WK, Taylor PR, Patterson KY, Hill AD, Moler JE, Patterson BH. A human model of selenium that integrates metabolism from selenite and selenomethionine. J Nutr 2011;141(4):708-717.
    [ PubMed Abstract ]
  • Zhang S, Krebs-Smith SM, Midthune D, Perez A, Buckman DW, Kipnis V, Freedman LS, Dodd KW, Carroll RJ. Fitting a bivariate measurement error model for episodically consumed dietary components. Int J Biostatistics 2011;7(1):1-32.
    [ PubMed Abstract ]
  • Zhang S, Midthune D, Guenther PM, Krebs-Smith SM, Kipnis V, Dodd KW, Buckman DW, Tooze JA, Freedman L, Carroll RJ. A new multivariate measurement error model with zero-inflated dietary data, and its application to dietary assessment. Ann Appl Stat 2011;5(2B):1456-1487.
    [ PubMed Abstract ]
  • Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD; PLCO Project Team. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) 2011;4(3):375-383.
    [ PubMed Abstract ]
  • Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, Sempos CT, Picciano MF. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010;140(4):817-822.
    [ PubMed Abstract ]
  • Bailey RL, McDowell MA, Dodd KW, Gahche JJ, Dwyer JT, Picciano MF. Total folate and folic acid intakes from foods and dietary supplements of US children aged 1-13 y. Am J Clin Nutr 2010;92(2):353-358.
    [ PubMed Abstract ]
  • Bailey RL, Mills JL, Yetley EA, Gahche JJ, Pfeiffer CM, Dwyer JT, Dodd KW, Sempos CT, Betz JM, Picciano MF. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States. Am J Clin Nutr 2010;92(2):383-389.
    [ PubMed Abstract ]
  • Baker SG. Simple and flexible classification via Swirls and Ripples. BMC Bioinformatics (accepted in principle).
    [ PubMed Abstract ]
  • Baker SG, Cappuccio A, Potter JD. Research on early-stage carcinogenesis: are we approaching paradigm instability? J Clin Oncol 2010;28:3215-3218.
    [ PubMed Abstract ]
  • Baker SG, Darke AK, Pinsky P, Parnes HL, Kramer BS. Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial. Biostatistics 2010;11(3):413-418.
    [ PubMed Abstract ]
  • Baker SG, Kramer BS. Evaluating Biomarkers For Cancer Screening Exit Disclaimer. Pharma IQ 31/08/2/2010, article ID: 3077.
  • Baker SG, Sargent DJ. Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk prediction. J Natl Cancer Inst 2010;102(23):1756-1759.
    [ PubMed Abstract ]
  • Belcher BR, Berrigan D, Dodd KW, Emken BA, Chou CP, Spuijt-Metz D. Physical activity in US youth: effect of race/ethnicity, age, gender, and weight status. Med Sci Sports Exerc 2010;42(12):2211-2221.
    [ PubMed Abstract ]
  • Berger VW. A Socratic dialogue. Journal of Applied Statistical Methods 2010;8(1):316-321.
  • Berger VW. Assessing the quality of randomization and allocation concealment. Osteoarthritis Cartilage 2010;18(10):1361; author reply 1362.
    [ PubMed Abstract ]
  • Berger VW. Assessing the quality of surgical trials: further insight. Ann Surg 2010 Dec 17;().
    [ PubMed Abstract ]
  • Berger VW. Exact permutation tests for correlated binomial variables: letter to the editor. Biometrical Journal 2010;52(3):436-437.
    [ PubMed Abstract ]
  • Berger VW. Making statistics boring again. Stat Med 2010;29(13);1458. [Letter to Editor]
    [ PubMed Abstract ]
  • Berger VW. Minimization, by its nature, precludes allocation concealment, and invites selection bias. Contemp Clin Trials 2010;31(5)406.
    [ PubMed Abstract ]
  • Berger VW. Permutation tests for stochastic ordering and ANOVA: theory and applications with R by BASSO, D., PESARIN, F., SALMASO, L., and SOLARI, A. Biometrics 2010;66(1):319-321.
  • Berger VW. Randomization, permuted blocks, masking, allocation concealment, and selection bias in the Tobacco Quit Line Study. Contemp Clin Trials 2010;31(3):201.
    [ PubMed Abstract ]
  • Berger VW. Testing for baseline balance: can we finally get it right? J Clin Epidemiol 2010;63(8)939-940; author reply 940-942.
    [ PubMed Abstract ]
  • Berger VW, Do AC. Allocation concealment continues to be misunderstood. J Clin Epidemiol 2010;63(4):468-469; author reply 469-470.
    [ PubMed Abstract ]
  • Berger VW, Grant WC, Vazquez LF. Sensitivity designs for preventing bias replication in randomized clinical trials. Stat Methods Med Res 2010;19(4):415-424.
    [ PubMed Abstract ]
  • Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG, Adenoma Prevention with Celecoxib (APC) Study Investigators (Corle D). Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prev Res 2010;3(5);588-596.
    [ PubMed Abstract ]
  • Black A, Grubb R, Church T, Reding D, Izmirlian G, Hickey T, Mabie J, Riley T, Ragard L, Prorok P, Berg C, Crawford D, Andriole G. Comparison of risk estimates of factors associated with prostate cancer incidence and mortality between screened and control arms in the PLCO Trial. J Urol 2010;183(4):e53-e54.
  • Bobe G, Murphy G, Rogers CJ, Hance KW, Albert PS, Laiyemo AO, Sansbury LB, Lanza E, Schatzkin A, Cross AJ. Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 2010;19(6)1441-1452.
    [ PubMed Abstract ]
  • Crawford ED, Izmirlian G, Grubb RL, Kramer BS, Church TR, Black A, Riley TM, Hickey T, Ragard L, Prorok PC, Berg CD, Andriole GL. Factors influencing prostate cancer mortality in the PLCO Trial. J Urol 2010;183(4):e224-e225.
  • Cronin KA, Harlan LC, Dodd KW, Abrams JS, Ballard-Barbash R. Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. Cancer Invest 2010;28(9):963-968.
    [ PubMed Abstract ]
  • Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med 2010;152(8):505-512, W176-180.
    [ PubMed Abstract ]
  • Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol 2010;37(3):202-215.
    [ PubMed Abstract ]
  • Doria-Rose VP, Marcus PM, Miller AB, Bergstralh EJ, Mandel JS, Tockman MS, Prorok PC. Does the source of death information affect cancer screening efficacy results? a study of the use of mortality review versus death certificates in four randomized trials. Clin Trials 2010;7(1):69-77.
    [ PubMed Abstract ]
  • Doubeni CA, Laiyemo AO, Klabunde CN, Young AC, Field TS, Fletcher RH. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med 2010;38(2):184-191.
    [ PubMed Abstract ]
  • Doubeni CA, Laiyemo AO, Young AC, Klabunde CN, Reed G, Field TS, Fletcher RH. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med 2010;8(4):299-307.
    [ PubMed Abstract ]
  • Freedman LS, Guenther PM, Dodd KW, Krebs-Smith SM, Midthune D. The population distribution of ratios of usual intakes of dietary components that are consumed every day can be estimated from repeated 24-hour recalls. J Nutr 2010;140(1):111-116.
    [ PubMed Abstract ]
  • Freedman LS, Guenther PM, Krebs-Smith SM, Dodd KW, Midthune D. A population's distribution of Healthy Eating Index-2005 component scores can be estimated when more than one 24-hour recall is available. J Nutr 2010;140(8)1529-1534.
    [ PubMed Abstract ]
  • Freedman LS, Kipnis V, Schatzkin A, Tasevska N, Potischman N. Can we use biomarkers in combination with self-reports to strengthen the analysis of nutritional epidemiologic studies? Epidemiol Perspect Innov 2010;7(1)2. (doi: 10.1186/1742-5573-7-2)
    [ PubMed Abstract ]
  • Freedman LS, Tasevska N, Kipnis V, Schatzkin A, Mares J, Tinker L, Potischman N. Gains in statistical power from using a dietary biomarker in combination with self-reported intake to strengthen the analysis of a diet-disease association: An example from CAREDS. Am J Epidemiol 2010;172(7):836-842.
    [ PubMed Abstract ]
  • Grubb RL, Black A, Shaul S, Mabie J, Riley T, Kattan M, Izmirlian G, Vickers AJ, Bochner BH, Kibel AS, Prorok PC, Berg CD, Stephenson A, Andriole GL. Predicting the risk of bladder cancer and high-grade bladder cancer using patient clinical and demographic information from PLCO participation. J Urol 2010:183(4):e448-e449.
  • Hocking WG, Hu P, Oken MM, Winslow SD, Kvale PA, Prorok PC, Ragard LR, Commins J, Lynch DA, Andriole GL, Buys SS, Fouad MN, Fuhrman CR, Isaacs C, Yokochi LA, Riley TL, Pinsky PF, Gohagan JK, Berg CD for the PLCO Project Team. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst 2010;102:1-10.
    [ PubMed Abstract ]
  • Imperiale TF, Ransohoff DF. Understanding differences in the guidelines for colorectal cancer screening. Gastroenterology 2010;138(5):1642-1647.e1.
    [ PubMed Abstract ]
  • Klabunde CN, Marcus PM, Silvestri GA, Han PKJ, Richards TB, Yuan G, Marcus SE, Vernon SW. U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am J Prev Med 2010;39(5):411-420.
    [ PubMed Abstract ]
  • Krebs Smith SM, Guenther PM, Subar AF, Kirkpatrick SI, Dodd KW. Americans do not meet Federal dietary recommendations. J Nutr 2010;140(10):1832-1828.
    [ PubMed Abstract ]
  • Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, Crawford ED, Kvale P, Fouad M, Hickey T, Riley T, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 2010;102(8):538-546.
    [ PubMed Abstract ]
  • Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010;21(1):163-170.
    [ PubMed Abstract ]
  • Leung K, Pinsky P, Laiyemo AO, Lanza E, Schatzkin A, Schoen RE. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study (PPT-CFS). Gastrointest Endosc 2010;71(1):111-117.
    [ PubMed Abstract ]
  • Marcus PM, Huang GC, Beck V, Miller MJ. The impact of a primetime cancer storyline: from individual knowledge and behavioral intentions to policy-level changes. J Cancer Educ 2010;25(4)484-489.
    [ PubMed Abstract ]
  • Meinhold CL, Dodd KW, Jiao L, Flood A, Shikany JM, Genkinger JM, Hayes RB, Stolzenberg-Solomon RZ. Available carbohydrates, glycemic load, and pancreatic cancer: is there a link? Am J Epidemiol 2010;171(11):1174-1182.
    [ PubMed Abstract ]
  • National Lung Screening Trial Research Team Writing Committee: Aberle DR, Adams A, Berg CD, Clapp J, Clingan K, Gareen IF, Lynch DA, Marcus PM, Pinsky P (Fagerstrom RF, Prorok PC). Baseline characteristics of participants in the National Lung Screening Trial. J Natl Cancer Inst 2010;102:1771-1779.
    [ PubMed Abstract ]
  • Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2010;91(2):449-455.
    [ PubMed Abstract ]
  • Pinsky PF, Black A, Kramer BS, Miller A, Prorok PC, Berg C. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2010;7(4)303-311.
    [ PubMed Abstract ]
  • Prorok PC, Marcus PM. Cancer screening trials: nuts and bolts. Semin Oncol 2010;37(3):216-223.
    [ PubMed Abstract ]
  • Ransohoff DF, Gourlay ML. Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncol 2010;28(4):698-704.
    [ PubMed Abstract ]
  • Ransohoff DF, Khoury MJ. Personal genomics: information can be harmful. Eur J Clin Invest 2010;40(1):64-68.
    [ PubMed Abstract ]
  • Ransohoff DF. Can endoscopy protect against colorectal cancer? an RCT. Lancet 2010;375(9726):1582-1584.
    [ PubMed Abstract ]
  • Ransohoff DF. Proteomics research to discover markers: what can we learn from Netflix? Clin Chem 2010;56(2):172-176.
    [ PubMed Abstract ]
  • Reedy J, Wirfält E, Flood A, Mitrou PN, Krebs-Smith SM, Kipnis V, Midthune D, Leitzmann M, Hollenbeck A, Schatzkin A, Subar AF. Comparing 3 dietary pattern methods--cluster analysis, factor analysis, and index analysis--with colorectal cancer risk: the NIH-AARP Diet and Health Study. Am J Epidemiol 2010;171(4):479-487.
    [ PubMed Abstract ]
  • Regnier FE, Skates SJ, Mesri M, Rodriguez H, Tezak Z, Kondratovich MV, Alterman MA, Levin JD, Roscoe D, Reilly E, Callaghan J, Kelm K, Brown D, Philip R, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Ransohoff DF, Mansfield E, Anderson NL. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin Chem 2010;56(2):165-171.
    [ PubMed Abstract ]
  • Rodriguez H, Tezak Z, Mesri M, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Philip R, Ransohoff DF, Skates SJ, Regnier FE, Anderson NL, Mansfield E, Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin Chem 2010;56(2):237-243.
    [ PubMed Abstract ]
  • Rosenfeld S. Do DNA microarrays tell the story of gene expression? Gene Regul Syst Bio 2010;4:61-73. (Early view)
    [ PubMed Abstract ]
  • Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Reding DJ, Hayes RB, Church T, Yurgalevich S, Doria-Rose VP, Hickey T, Riley T, Berg CD. Utilization of surveillance colonoscopy in community practice. Gastroenterology 2010;138(1):73-81.
    [ PubMed Abstract ]
  • Sinha S, Mallick BK, Kipnis V, Carroll RJ. Semiparametric Bayesian analysis of nutritional epidemiology data in the presence of measurement error. Biometrics 2010;66:444-454.
    [ PubMed Abstract ]
  • The National Lung Screening Trial Research Team (Writing Committee: Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen, IF, Lynch DA, Marcus PM, Pinsky PF. Baseline characteristics of participants in the randomized National Lung Screening Trial. J Natl Cancer Inst 2010;102:1771-1779.
    [ PubMed Abstract ]
  • Tooze JA, Kipnis V, Buckman DW, Carroll RJ, Freedman LS, Guenther PM, Krebs-Smith SM, Subar AF, Dodd KW. A mixed-effects model approach for estimating the distribution of usual intake of nutrients: the NCI method. Stat Med 2010;29(27):2857-2868.
    [ PubMed Abstract ]
  • Zweig M, DeVoto E. Does the language fit the evidence?--Association versus causation. HealthNewsReview.org Feb 10, 2010.


Back to top